LPA and chronic kidney disease: The association between elevated Lp (a) levels and incident myocardial infarction and mortality was assessed among the participants of the Chronic Renal Insufficiency Cohort (CRIC) study followed up for 7.5 years; the study found that the highest quartile of Lp (a), with baseline levels > 61.3 mg/dl was associated with increased risk of myocardial infarction (HR 1.49; 95% CI – 1.05–2.11) and death (HR 1.28; 95% CI – 1.05–1.57) [10].